13F HOLDINGS REPORT
Ally Bridge Group (NY) LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0000950123-24-005227
Total Value
$179.9M
Positions
22
Other Managers
1
Confidential Omitted
No
Holdings (22)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BLUEPRINT MEDICINES CORP | 09627Y109 | 160,950 | $15.3M | 8.49% |
| 2 | SOLENO THERAPEUTICS INC | SLNO | 336,486 | $14.4M | 8.01% |
| 3 | CG ONCOLOGY INC | CGON | 320,378 | $14.1M | 7.82% |
| 4 | XENON PHARMACEUTICALS INC | XENE | 309,369 | $13.3M | 7.40% |
| 5 | VERONA PHARMA PLC | 925050106 | 736,738 | $11.9M | 6.59% |
| 6 | MERUS N V | N5749R100 | 255,928 | $11.5M | 6.41% |
| 7 | PRAXIS PRECISION MEDICINES I | PRAX | 159,486 | $9.7M | 5.41% |
| 8 | MIND MEDICINE MINDMED INC | 60255C885 | 1,001,452 | $9.4M | 5.23% |
| 9 | AVADEL PHARMACEUTICALS PLC | 05337M104 | 547,036 | $9.2M | 5.14% |
| 10 | GERON CORP | GERN | 2,760,497 | $9.1M | 5.06% |
| 11 | JASPER THERAPEUTICS INC | JSPRW | 289,943 | $8.5M | 4.73% |
| 12 | KURA ONCOLOGY INC | KURA | 365,044 | $7.8M | 4.33% |
| 13 | INSMED INC | INSM | 250,000 | $6.8M | 3.77% |
| 14 | DIANTHUS THERAPEUTICS INC | DNTH | 216,968 | $6.5M | 3.62% |
| 15 | OLEMA PHARMACEUTICALS INC | OLMA | 559,035 | $6.3M | 3.52% |
| 16 | LYRA THERAPEUTICS INC | LYRA | 1,003,741 | $6.2M | 3.47% |
| 17 | LONGBOARD PHARMACEUTICALS IN | 54300N103 | 270,559 | $5.8M | 3.25% |
| 18 | RAPT THERAPEUTICS INC | 75382E109 | 420,000 | $3.8M | 2.10% |
| 19 | MERSANA THERAPEUTICS INC | 59045L106 | 801,437 | $3.6M | 2.00% |
| 20 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 394,773 | $3.6M | 1.98% |
| 21 | PROMIS NEUROSCIENCES INC | PMN | 1,059,582 | $2.0M | 1.13% |
| 22 | CONTEXT THERAPEUTICS INC | CNTX | 725,951 | $1.0M | 0.56% |